Hackett Group (HCKT) Q1 2026 Earnings Transcript

Hackett Group reported Q1 revenue before reimbursements of $67.8 million, down 11% year over year, with adjusted EPS of $0.34 versus $0.41 last year and adjusted EBITDA of $13.8 million. Management guided Q2 revenue to $68.5 million-$70 million and EPS to $0.33-$0.35 while flagging a $500,000 AI transition charge, but said Q3 should be an inflection point as AI platform-enabled delivery improves margins and earnings. The company also highlighted AI-related product adoption, IBM and Celonis go-to-market efforts, a 500 bp improvement in U.S. S&BT project margins, and continued capital returns via a $0.12 dividend and $4.6 million of buybacks.

Analysis

This quarter is less about a cyclical miss and more about a forced operating model rewrite. The key second-order effect is that HCKT is trying to convert labor arbitrage into platform leverage before demand fully re-accelerates, which temporarily compresses utilization and cash conversion even as it expands long-run gross margin capacity. That makes near-term earnings quality look worse than the guide implies because the company is intentionally front-loading severance, skill mix reset, and go-to-market retooling ahead of the revenue inflection.

The market is likely underestimating how binary the next 1-2 quarters are for the equity. If the Q2 sequential revenue rebound and the stated Q3 EPS inflection land, the stock can re-rate quickly because the narrative shifts from "consulting slowdown" to "AI-enabled margin expansion," and the balance sheet can support buybacks/dividends despite the low cash balance via improved working capital. If that cash conversion fails to materialize, however, the combination of higher DSO, milestone billing, and recurring restructuring can force the market to view the platform story as self-inflicted margin dilution rather than transformation.

IBM is the most important optionality vector, but the payoff is not immediate revenue — it's distribution. The partnership can act as a credibility wrapper that lowers enterprise procurement friction and helps HCKT get pulled into larger transformation budgets, while the Celonis/Hyperscaler inbound suggests the company may be becoming a niche validation layer for AI ROI assessments. The contrarian risk is that this also invites faster competitive imitation from larger services and software vendors, meaning the moat has to show up in conversion rates, not just demos. In that sense, the real catalyst is proof of sustained win rates and margin expansion in Q3, not the partnership announcements themselves.

Key Decisions for Investors

• Buy HCKT into the next 2-4 weeks only on weakness below the post-earnings support zone; use a tight stop if Q2 bookings commentary does not confirm sequential improvement. Risk/reward is attractive only if you believe Q3 margin expansion is real, not just guided.
• For a higher-conviction expression, buy HCKT Jan-2027 call spreads to capture the 2H26 inflection while limiting downside to the execution risk around DSO and transition charges.
• Pair trade: long HCKT / short a basket of legacy labor-heavy IT services names over the next 1-2 quarters. The relative winner should be the firm with the clearest platform monetization path; the short leg benefits if the market rotates away from low-differentiation services models.
• Avoid chasing IBM solely on the partnership headline; treat it as a medium-term distribution option. Reassess only if the next quarter shows measurable sourced pipeline or booked deals tied to the collaboration.
• If HCKT rallies sharply before Q3 proof points, fade part of the move via covered calls or reduced exposure; the setup still has execution risk, and the stock can retrace if working-capital improvement does not offset the transition drag.